CTOs on the Move

Corizon

www.asgr.com

 
America Service Group Inc. (ASG) through its subsidiaries Prison Health Services, Inc. (PHS), EMSA Limited Partnership (EMSA), and Correctional Health Services, LLC (CHS), contracts to provide and/or administer managed healthcare services to over 120
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.asgr.com
  • 105 Westpark Dr Ste 200
    Brentwood, TN USA 37027
  • Phone: 615.373.3100

Executives

Name Title Contact Details

Similar Companies

United Veterinary Care

Your vision. Our resources. Together we can build a bright future for your practice and the veterinary industry as a whole.

Goddard USD

Goddard USD is a Goddard, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greeley Place Retirement

Greeley Place Retirement is a Greeley, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Home Care Medical

Serving Southeastern Wisconsin since 1974, Home Care Medical, Inc. provides home infusion, enteral nutrition and hospice care; rehab technology; respiratory care; home medical equipment and supplies; and bracing and compression garments. In addition to the Corporate Headquarters located at 5665 South Westridge Drive in New Berlin, Wisconsin, Home Care Medical, Inc. has three retail store locations at 4818 South 76th Street in Milwaukee, Wisconsin; 2922 South Business Drive in Sheboygan, Wisconsin; and 1709 South 18th Avenue in West Bend, Wisconsin. Home Care Medical, Inc. is the WAMES (Wisconsin Association of Medical Equipment Services) HME Provider of the Year award recipient in 2013 and 2012. Accredited by the Joint Commission and an active member of WAMES, the MedGroup and AAHomecare, Home Care Medical’s mission is to enhance the lives of those we serve.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III